...
首页> 外文期刊>Drug development and industrial pharmacy >Modified drug release of poloxamer matrix by including water-soluble and water-insoluble polymer
【24h】

Modified drug release of poloxamer matrix by including water-soluble and water-insoluble polymer

机译:通过包含水溶性和水不溶性聚合物改善泊洛沙姆基质的药物释放

获取原文
获取原文并翻译 | 示例
           

摘要

Background: The ability of poloxamer 407 to control drug release was investigated along with the effect of incorporation of a second polymer with poloxamer on dissolution behavior. Methods: Tablets made of 30% w/w/ theophylline and 15%, 25%, 50%, or 69% poloxamer were prepared. Additionally, tablets containing mixture of poloxamer with carbomer or hypromellose in a 1:1 ratio and at different total levels (15%, 30%, and 50%) were also tested. Results: Data show that as the level of poloxamer increased, drug release decreased. Formulations containing poloxamer: hypromellose 1:1 at 50% level and formulations containing poloxamer: carbomer 1:1 at 30% level produced controlled release matrices over 24 hours of testing dissolution. The mechanism of drug release follows anomalous relaxation non-Fickian diffusion model. Conclusions: These results suggest that the combination of poloxamer 407 with hypromellose or carbomer is feasible and has potential to offer the formulator control over drug release.
机译:背景:研究了泊洛沙姆407控制药物释放的能力,以及第二种聚合物与泊洛沙姆的掺入对溶出行为的影响。方法:制备由30%w / w /茶碱和15%,25%,50%或69%泊洛沙姆制成的片剂。另外,还测试了含有泊洛沙姆与卡波姆或羟丙甲纤维素的比例为1:1且总含量不同(15%,30%和50%)的片剂。结果:数据表明,随着泊洛沙姆水平的增加,药物的释放减少。含有泊洛沙姆:羟丙甲纤维素1:1(50%水平)的制剂和含有泊洛沙姆:卡波姆1:1(30%水平)的制剂在测试溶出度的24小时内产生了控释基质。药物释放的机理遵循异常松弛非菲克扩散模型。结论:这些结果表明,泊洛沙姆407与羟丙甲纤维素或卡波姆的组合是可行的,并具有为配方设计师控制药物释放的潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号